Intranasal Delivery of Recombinant NT4-NAP/AAV Exerts Potential Antidepressant Effect

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Neurochemical Research

• Publication date

  2016-02-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11064-016-1841-0PMID 26846142
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anatomy and physiology of the blood-brain barrier.

  2015cited by this paper
• Habituation-Like Decrease of Acetylcholine-Induced Inward Current in Helix Command Neurons: Role of Microtubule Motor Proteins

  2015cited by this paper
• The NAP motif of activity-dependent neuroprotective protein (ADNP) regulates dendritic spines through microtubule end binding proteins

  2014cited by this paper
• Davunetide: Peptide therapeutic in neurological disorders.

  2014cited by this paper
• Insights into direct nose to brain delivery: current status and future perspective

  2014cited by this paper
• Strategies to deliver peptide drugs to the brain.

  2014cited by this paper
• Microtubule-stabilizing peptides and small molecules protecting axonal transport and brain function: focus on davunetide (NAP).

  2013cited by this paper
• NAP (davunetide) modifies disease progression in a mouse model of severe neurodegeneration: protection against impairments in axonal transport.

  2013cited by this paper
• A breach in the scaffold: the possible role of cytoskeleton dysfunction in the pathogenesis of major depression.

  2013cited by this paper
• Davunetide: a review of safety and efficacy data with a focus on neurodegenerative diseases

  2013cited by this paper
• D-NAP Prophylactic Treatment in the SOD Mutant Mouse Model of Amyotrophic Lateral Sclerosis: Review of Discovery and Treatment of Tauopathy

  2012cited by this paper
• Tau and Caspase 3 as Targets for Neuroprotection

  2012cited by this paper
• Adeno-associated viral vector-mediated expression of NT4-ADNF-9 fusion gene protects against aminoglycoside-induced auditory hair cell loss in vitro

  2011cited by this paper
• Delivery of Brain-Derived Neurotrophic Factor via Nose-to-Brain Pathway

  2011cited by this paper
• A pilot trial of the microtubule-interacting peptide (NAP) in mice overexpressing alpha-synuclein shows improvement in motor function and reduction of alpha-synuclein inclusions.

  2011cited by this paper
• NAP (davunetide) enhances cognitive behavior in the STOP heterozygous mouse--a microtubule-deficient model of schizophrenia.

  2010cited by this paper
• An effective quality system approach for the qualification of excipient suppliers

  2009cited by this paper
• Detection of Intact rAAV Particles up to 6 Years After Successful Gene Transfer in the Retina of Dogs and Primates.

  2009cited by this paper
• Direct nose-to-brain transfer of a growth hormone releasing neuropeptide, hexarelin after intranasal administration to rabbits.

  2009cited by this paper
• Nanoparticles for direct nose-to-brain delivery of drugs.

  2009cited by this paper
• Detection of intact rAAV particles up to 6 years after successful gene transfer in the retina of dogs and primates.

  2009cited by this paper
• Davunetide Pharmacokinetics and distribution to brain after intravenous or intranasal administration to rat

  2009cited by this paper
• Sex differences in tolerance to the locomotor depressant effects of lobeline in periadolescent rats.

  2009cited by this paper
• Differentiating antidepressants of the future: efficacy and safety.

  2007cited by this paper
• Molecular studies of major depressive disorder: the epigenetic perspective

  2007cited by this paper
• NAP: research and development of a peptide derived from activity-dependent neuroprotective protein (ADNP).

  2006cited by this paper
• Nasal drug administration: potential for targeted central nervous system delivery.

  2005cited by this paper
• A Femtomolar Acting Octapeptide Interacts with Tubulin and Protects Astrocytes against Zinc Intoxication*

  2004cited by this paper
• The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

  2003cited by this paper
• Brain delivery of vasoactive intestinal peptide (VIP) following nasal administration to rats.

  2003cited by this paper
• The molecular motor toolbox for intracellular transport.

  2003cited by this paper
• NAP accelerates the performance of normal rats in the water maze

  2002cited by this paper
• Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors

  2001cited by this paper
• Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease.

  2000cited by this paper
• Complete Sequence of a Novel Protein Containing a Femtomolar‐Activity‐Dependent Neuroprotective Peptide

  1999cited by this paper
• The blood brain barrier: anatomy and physiology.

  1972cited by this paper

• Intranasal versus intravenous AAV delivery: A comparative analysis of brain-targeting efficiency and peripheral exposure in mice.

  2025cites this paper
• Research progress of neurotrophic factor 4 in nerve injury repair

  2024cites this paper
• Intranasal Application of Adeno-Associated Viruses: A Systematic Review.

  2022cites this paper
• Application of Intranasal Administration in the Delivery of Antidepressant Active Ingredients

  2022cites this paper
• Activity-dependent neuroprotective protein (ADNP)/NAP (CP201): Autism, schizophrenia, and Alzheimer’s disease

  2020cites this paper
• Recent Advances in Preclinical Studies and Potential Applications of Dendrimers as Drug Carriers in the Central Nervous System.

  2017cites this paper
• Intranasal Adeno-Associated Virus Mediated Gene Delivery and Expression of Human Iduronidase in the Central Nervous System: A Noninvasive and Effective Approach for Prevention of Neurologic Disease in Mucopolysaccharidosis Type I

  2017cites this paper
• Antidepressant effect of recombinant NT4-NAP/AAV on social isolated mice through intranasal route

  2016cites this paper